feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Weight-Loss Jab's Hidden Cost: Shocking Hair Loss

Weight-Loss Jab's Hidden Cost: Shocking Hair Loss

8 Feb

Summary

  • GLP-1 drugs linked to increased risk of hair loss.
  • Some users experience shedding not related to rapid weight loss.
  • Experts debate between nutritional deficiency and hormonal changes.
Weight-Loss Jab's Hidden Cost: Shocking Hair Loss

Weight-loss medications, including Mounjaro and Ozempic, have gained popularity for their efficacy in shedding pounds and improving health. However, a distressing side effect, significant hair loss, is increasingly reported by users. While some experts suggest nutritional deficiencies from dieting cause this shedding, many individuals experience it despite maintaining a healthy diet and losing weight gradually.

A recent US study indicated a higher incidence of 'telogen effluvium' and 'androgenic alopecia' in women taking semaglutide. This has fueled concerns that these GLP-1 drugs might trigger early-onset female pattern baldness, potentially due to hormonal imbalances. Medical professionals are exploring the link between these medications and hair loss, with some suggesting pharmaceutical companies should fund further research into the phenomenon.

While some cases are temporary, stemming from stress or nutritional factors, the possibility of permanent hair loss remains a significant worry for many. Experts emphasize seeking professional advice and proper screening for deficiencies, cautioning against unverified social media claims and 'miracle cures' that exploit these fears.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, significant hair loss is an emerging side effect reported by users of weight-loss medications such as Mounjaro and Ozempic, even when not experiencing rapid weight loss.
While some cases of hair loss associated with GLP-1 drugs are temporary and linked to stress or nutritional factors, there are concerns that it could trigger early-onset female pattern baldness in some individuals.
If experiencing hair loss, it is recommended to seek professional advice, undergo screening for nutritional deficiencies, and be wary of unverified social media claims or expensive 'miracle cures'.

Read more news on

Healthside-arrow
•
trending

Man City defeats Liverpool

trending

Yildiz extends Juventus contract

trending

Juventus vs Lazio: Key Battles

trending

Everton beat AFC Bournemouth

trending

Leverkusen draw stops winning streak

trending

Real Madrid vs Valencia live

trending

PSG vs Marseille live stream

You may also like

Nature's Ozempic? Expert Debunks Weight Loss Myths

1 day ago • 9 reads

article image

Expert Warns of 'Eye Stroke' from Ozempic

5 Feb • 14 reads

article image

New Skin Cancer Therapy Halves Recurrence Risk

20 Jan • 116 reads

article image

Eggs: Your Secret Weapon After Weight-Loss Injections?

7 Jan • 159 reads

article image

Breakthrough in Heart Disease: Novel Lp(a) Treatments Emerge

3 Jan • 173 reads

article image